Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
Key facts
- Who runs it
- Beijing Tiantan Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 31,595 people enrolled
- Started
- 1 Dec 2021
- Ended
- 1 Dec 2024
- Type of study
- Observational, 3 groups
- Treatments tested
- observation
- Record updated
- 6 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- age > 18 years. B. at least one intracranial aneurysm needs to be treated by craniotomy, endovascular treatment or combined surgery
- patients' consent were obtained
Who cannot take part
- Ruptured intracranial aneurysms, accompanied by subarachnoid hemorrhage or cerebral hemorrhage
- Combined with brain tumors or malignant tumors in other parts
- Combined with systemic connective tissue disease and systemic rheumatic disease
- Due to other diseases, or poor general condition, the expected survival time is not more than 12 months
- Traumatic, infectious and atrial myxoma-associated intracranial aneurysms
- Combined with cerebrovascular malformations
- During pregnancy and perinatal period
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this prospective observational cohort study is to learn about treatment strategies for unruptured intracranial aneurysms in the Chinese population. The main questions it aims to answer are:
Read full original descriptionShow less
* To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy. * To establish clinical management path for patients with unruptured intracranial aneurysm.
According to the treatment of all patients with unruptured intracranial aneurysm, they were divided into the following groups: 1. Conservative treatment group; 2. Intracranial aneurysm clipping group; 3. Coil embolization or stent-assisted coil embolization group; 4. Flow diversion group.
The 3 groups in the trial
- Intracranial aneurysm clipping group
Patients in Intracranial aneurysm clipping group receive neurosurgical clipping.
Treatment: observation
- Coil embolization or stent-assisted coil embolization group
Patients in coil embolization or stent-assisted coil embolization group receive coil embolization or stent-assisted coil embolization according to individualized condition.
Treatment: observation
- Flow diversion group.
Patients in flow diversion group receive flow diverters.
Treatment: observation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Infection and quality of life after local or full scalp shaving in microsurgical treatment for unruptured intracranial aneurysm sited in anterior circulation.Chinese neurosurgical journal, 2026
- Different duration of dual antiplatelet therapy after endovascular treatment for unruptured intracranial aneurysms.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2026
- Treatment strategies for unruptured intracranial aneurysms in the Chinese population: China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA).Chinese neurosurgical journal, 2025
- Record updated
- 6 April 2026